Evidence map›Paper›PMID 39858911›Full record

ArticleMicroorganisms2025

Decitabine Increases the Transcription of

Shaotang Ye, Zhen Wang, Aolei Chen, Ying Chen, Gaoming Lou, Qingmei Xie, Gang Lu, Shoujun Li

Abstract read
In one paragraph

Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shaotang YeCollege of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.ORCID 0000-0001-8891-9756
Zhen WangCollege of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
Aolei ChenCollege of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
Ying ChenCollege of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
Gaoming LouHenry Fok School of Biology and Agriculture, Shaoguan University, Shaoguan 512005, China.
Qingmei XieCollege of Animal Science, South China Agricultural University, Guangzhou 510642, China.
Gang LuCollege of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
Shoujun LiCollege of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.

Funding

National Natural Science Foundation of China 31872454
6 · The paper itself

Abstract

Developing novel antiviral drugs has always been a significant forefront in biological medicine research. Antiviral drugs can be extracted, purified, and synthesized from various biological sources and by different methods. However, they are less explored in veterinary medicine for animal viruses. This research primarily selected feline calicivirus (FCV) to screen the novel antiviral drug against animal viruses. A preliminary screening from a natural product library was conducted, with subsequent assessments to ascertain their toxicity levels and antiviral capabilities. The results showed that decitabine and alprostadil were effective in reducing FCV replication. The decitabine (5-aza-2'-deoxycytidine) was selected for antiviral mechanism investigation. Decitabine has been proven to modulate gene expression through its demethylating effect. Thus, we carried out further experiments and found that decitabine inhibited the FCV by enhancing the transcription of the feline

Indexed as

antiviralcanine influenza virusdecitabinefeline calicivirusRIG-I

Identifiers

PMID39858911
PMCPMC11767338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.